Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Protara Therapeutics Inc (NASDAQ: TARA) closed at $2.8 down -7.59% from its previous closing price of $3.03. In other words, the price has decreased by -$7.59 from its previous closing price. On the day, 0.53 million shares were traded. TARA stock price reached its highest trading level at $3.095 during the session, while it also had its lowest trading level at $2.79.
Ratios:
For a deeper understanding of Protara Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.03 and its Current Ratio is at 18.03. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Scotiabank on April 16, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $12.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 14 ’25 when Levy Richard S bought 20,000 shares for $3.19 per share. The transaction valued at 63,800 led to the insider holds 51,000 shares of the business.
Zummo Jacqueline sold 21,224 shares of TARA for $96,145 on Mar 26 ’25. The Chf Scientific Operations Off now owns 98,861 shares after completing the transaction at $4.53 per share. On Mar 26 ’25, another insider, Zummo Jacqueline, who serves as the Officer of the company, bought 21,224 shares for $4.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARA now has a Market Capitalization of 116903080 and an Enterprise Value of -3232955.
Stock Price History:
The Beta on a monthly basis for TARA is 1.35, which has changed by 0.33333337 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, TARA has reached a high of $10.48, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is -15.06%, while the 200-Day Moving Average is calculated to be -21.76%.
Shares Statistics:
For the past three months, TARA has traded an average of 434.31K shares per day and 751800 over the past ten days. A total of 38.58M shares are outstanding, with a floating share count of 34.42M. Insiders hold about 10.78% of the company’s shares, while institutions hold 69.41% stake in the company. Shares short for TARA as of 1749772800 were 2203964 with a Short Ratio of 5.07, compared to 1747267200 on 2248332. Therefore, it implies a Short% of Shares Outstanding of 2203964 and a Short% of Float of 5.86.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
